methyl (15S,16R,18S)-15-methyl-16-(methylamino)-3-oxo-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylate
| Internal ID | 0487af2a-7edf-40f7-a25b-c77e9f7de90f |
| Taxonomy | Organoheterocyclic compounds > Indoles and derivatives > Carbazoles > Pyrrolocarbazoles > Indolocarbazoles |
| IUPAC Name | methyl (15S,16R,18S)-15-methyl-16-(methylamino)-3-oxo-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylate |
| SMILES (Canonical) | CC12CC(CC1(C(=O)OC)NC)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O |
| SMILES (Isomeric) | C[C@]12C[C@H](C[C@@]1(C(=O)OC)NC)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O |
| InChI | InChI=1S/C29H26N4O3/c1-28-12-15(13-29(28,30-2)27(35)36-3)32-19-10-6-4-8-16(19)22-23-18(14-31-26(23)34)21-17-9-5-7-11-20(17)33(28)25(21)24(22)32/h4-11,15,30H,12-14H2,1-3H3,(H,31,34)/t15-,28+,29+/m1/s1 |
| InChI Key | FVXOMLUAKMELPE-JPLMGPNHSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C29H26N4O3 |
| Molecular Weight | 478.50 g/mol |
| Exact Mass | 478.20049070 g/mol |
| Topological Polar Surface Area (TPSA) | 77.30 Ų |
| XlogP | 3.30 |
| Atomic LogP (AlogP) | 4.34 |
| H-Bond Acceptor | 6 |
| H-Bond Donor | 2 |
| Rotatable Bonds | 2 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9366 | 93.66% |
| Caco-2 | - | 0.6981 | 69.81% |
| Blood Brain Barrier | + | 0.6000 | 60.00% |
| Human oral bioavailability | + | 0.5714 | 57.14% |
| Subcellular localzation | Lysosomes | 0.6002 | 60.02% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8926 | 89.26% |
| OATP1B3 inhibitior | + | 0.9341 | 93.41% |
| MATE1 inhibitior | - | 0.7600 | 76.00% |
| OCT2 inhibitior | - | 0.7359 | 73.59% |
| BSEP inhibitior | + | 0.8828 | 88.28% |
| P-glycoprotein inhibitior | + | 0.7711 | 77.11% |
| P-glycoprotein substrate | + | 0.8138 | 81.38% |
| CYP3A4 substrate | + | 0.7084 | 70.84% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8248 | 82.48% |
| CYP3A4 inhibition | + | 0.7125 | 71.25% |
| CYP2C9 inhibition | + | 0.5161 | 51.61% |
| CYP2C19 inhibition | + | 0.5429 | 54.29% |
| CYP2D6 inhibition | - | 0.7706 | 77.06% |
| CYP1A2 inhibition | + | 0.5589 | 55.89% |
| CYP2C8 inhibition | + | 0.6222 | 62.22% |
| CYP inhibitory promiscuity | + | 0.5759 | 57.59% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8700 | 87.00% |
| Carcinogenicity (trinary) | Non-required | 0.6450 | 64.50% |
| Eye corrosion | - | 0.9893 | 98.93% |
| Eye irritation | - | 0.9867 | 98.67% |
| Skin irritation | - | 0.7930 | 79.30% |
| Skin corrosion | - | 0.9402 | 94.02% |
| Ames mutagenesis | + | 0.6082 | 60.82% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.8637 | 86.37% |
| Micronuclear | + | 0.7500 | 75.00% |
| Hepatotoxicity | - | 0.5428 | 54.28% |
| skin sensitisation | - | 0.8793 | 87.93% |
| Respiratory toxicity | + | 0.8333 | 83.33% |
| Reproductive toxicity | + | 0.9222 | 92.22% |
| Mitochondrial toxicity | + | 0.8750 | 87.50% |
| Nephrotoxicity | - | 0.7310 | 73.10% |
| Acute Oral Toxicity (c) | III | 0.5361 | 53.61% |
| Estrogen receptor binding | + | 0.8111 | 81.11% |
| Androgen receptor binding | + | 0.7000 | 70.00% |
| Thyroid receptor binding | + | 0.6466 | 64.66% |
| Glucocorticoid receptor binding | + | 0.6977 | 69.77% |
| Aromatase binding | + | 0.6557 | 65.57% |
| PPAR gamma | + | 0.6879 | 68.79% |
| Honey bee toxicity | - | 0.7788 | 77.88% |
| Biodegradation | - | 0.9000 | 90.00% |
| Crustacea aquatic toxicity | + | 0.5600 | 56.00% |
| Fish aquatic toxicity | + | 0.9772 | 97.72% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 99.26% | 94.45% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.83% | 91.11% |
| CHEMBL2041 | P07949 | Tyrosine-protein kinase receptor RET | 98.61% | 91.79% |
| CHEMBL2708 | Q16584 | Mitogen-activated protein kinase kinase kinase 11 | 98.44% | 81.14% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 98.14% | 85.14% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 96.65% | 96.09% |
| CHEMBL4224 | P49759 | Dual specificty protein kinase CLK1 | 96.47% | 85.30% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 95.63% | 95.56% |
| CHEMBL2581 | P07339 | Cathepsin D | 95.42% | 98.95% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 95.38% | 87.16% |
| CHEMBL1974 | P36888 | Tyrosine-protein kinase receptor FLT3 | 94.78% | 91.83% |
| CHEMBL4578 | Q14680 | Maternal embryonic leucine zipper kinase | 94.61% | 81.58% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 94.49% | 80.71% |
| CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 93.91% | 88.81% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 93.66% | 93.03% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 92.92% | 83.10% |
| CHEMBL3788 | O00444 | Serine/threonine-protein kinase PLK4 | 92.91% | 83.65% |
| CHEMBL1868 | P17948 | Vascular endothelial growth factor receptor 1 | 92.23% | 96.47% |
| CHEMBL5284 | Q96RR4 | CaM-kinase kinase beta | 92.19% | 89.23% |
| CHEMBL2345 | P51812 | Ribosomal protein S6 kinase alpha 3 | 91.64% | 95.64% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 91.21% | 89.00% |
| CHEMBL2095172 | P14867 | GABA-A receptor; alpha-1/beta-2/gamma-2 | 90.95% | 92.67% |
| CHEMBL4924 | Q9UK32 | Ribosomal protein S6 kinase alpha 6 | 90.90% | 80.00% |
| CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 90.56% | 90.95% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 90.52% | 80.00% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 90.21% | 99.23% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 89.45% | 95.83% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 88.81% | 98.59% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 88.58% | 91.07% |
| CHEMBL2801 | Q13557 | CaM kinase II delta | 88.54% | 84.49% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 88.32% | 95.89% |
| CHEMBL2094127 | P06493 | Cyclin-dependent kinase 1/cyclin B | 88.30% | 96.00% |
| CHEMBL2535 | P11166 | Glucose transporter | 86.70% | 98.75% |
| CHEMBL4598 | Q13043 | Serine/threonine-protein kinase MST1 | 86.59% | 96.64% |
| CHEMBL1936 | P10721 | Stem cell growth factor receptor | 85.72% | 84.17% |
| CHEMBL301 | P24941 | Cyclin-dependent kinase 2 | 85.51% | 91.23% |
| CHEMBL5314 | Q06418 | Tyrosine-protein kinase receptor TYRO3 | 85.00% | 96.00% |
| CHEMBL4355 | O14976 | Serine/threonine-protein kinase GAK | 84.45% | 89.32% |
| CHEMBL4482 | O96013 | Serine/threonine-protein kinase PAK 4 | 84.13% | 95.42% |
| CHEMBL5408 | Q9UHD2 | Serine/threonine-protein kinase TBK1 | 83.31% | 90.48% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 83.14% | 90.00% |
| CHEMBL5678 | P34947 | G protein-coupled receptor kinase 5 | 82.93% | 88.00% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 82.64% | 82.69% |
| CHEMBL3820 | P35557 | Hexokinase type IV | 81.46% | 91.96% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 80.60% | 97.25% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 80.55% | 97.14% |
| CHEMBL216 | P11229 | Muscarinic acetylcholine receptor M1 | 80.26% | 94.23% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 80.20% | 94.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 163108805 |
| LOTUS | LTS0172127 |
| wikiData | Q105002947 |